Glostrup, Denmark

Eva Louise Hansen

USPTO Granted Patents = 7 

Average Co-Inventor Count = 4.4

ph-index = 7

Forward Citations = 200(Granted Patents)


Location History:

  • 4573 Højby, DK (2007)
  • Højby, DK (2009)
  • Glostrup, DK (2004 - 2017)

Company Filing History:


Years Active: 2004-2017

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations by Eva Louise Hansen

Introduction

Eva Louise Hansen is a notable inventor based in Glostrup, Denmark. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target serotonergic receptor activity. With a total of seven patents to her name, Hansen's work has the potential to impact various disease conditions.

Latest Patents

Among her latest patents, Hansen has developed methods of treatment using selective 5-HT2A inverse agonists. These compounds and methods are designed for the treatment of disease conditions where modification of serotonergic receptor activity can provide beneficial effects. In her method, an effective amount of a compound is administered to a patient in need of such treatment. Additionally, she has patented azacyclic compounds, which also aim to modify serotonergic receptor activity for therapeutic benefits.

Career Highlights

Hansen has worked with Acadia Pharmaceuticals Inc., where she has contributed her expertise in medicinal chemistry. Her innovative approaches have led to advancements in the treatment of various conditions, showcasing her dedication to improving patient outcomes.

Collaborations

Hansen has collaborated with notable professionals in her field, including Carl-Magnus A Andersson and Glenn Croston. These partnerships have further enhanced her research and development efforts.

Conclusion

Eva Louise Hansen's contributions to medicinal chemistry through her patents and collaborations highlight her role as a leading inventor in her field. Her work continues to pave the way for innovative treatments that can significantly benefit patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…